SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Fazio George

(Last)

(First)

(Middle)

ONE LILLEHEI PLAZA

(Street)

ST. PAUL

55117

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/30/2004

3. Issuer Name and Ticker or Trading Symbol
ST JUDE MEDICAL INC [ STJ ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President, Cardiac Surgery Div

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	5,647	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Right to Buy	12/18/1998	12/18/2007	Common Stock	2,250	$18.59	D
Right to Buy	12/18/1999	12/18/2007	Common Stock	1,800	$18.59	D
Right to Buy	12/01/2000	12/01/2008	Common Stock	750	$15.06	D
Right to Buy	12/01/1999	12/01/2008	Common Stock	1,876	$15.06	D
Right to Buy	05/03/2000	05/03/2009	Common Stock	3,000	$14.64	D
Right to Buy	12/13/2001	12/13/2010	Common Stock	30,000⁽¹⁾	$26.28	D
Right to Buy	07/03/2001	07/03/2010	Common Stock	42,000	$22.56	D
Right to Buy	06/28/2002	06/28/2009	Common Stock	40,000⁽¹⁾	$30.85	D
Right to Buy	12/10/2002	12/10/2009	Common Stock	30,000⁽¹⁾	$36.51	D
Right to Buy	12/09/2003	12/09/2010	Common Stock	23,000⁽¹⁾	$34.72	D
Right to Buy	12/08/2004	12/08/2011	Common Stock	19,900⁽¹⁾	$61.9	D
Right to Buy	08/30/2005	08/30/2012	Common Stock	5,000⁽¹⁾	$66.25	D
Right to Buy	12/31/2001	05/01/2007	Common Stock	1,500	$16.21	D
Right to Buy	05/01/1998	05/01/2007	Common Stock	1,500⁽¹⁾	$16.21	D

Explanation of Responses:

1. Shares vest twenty five percent per year for four years.

	Kevin T. O'Malley as Attorney in Fact	09/10/2004
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.